Healthcare >> Analyst Interviews >> February 1, 1999
JEFFREY J. KRAWS is a Pharmaceutical Analyst at Gruntal & Company,
L.L.C., focusing on large cap pharmaceutical, specialty pharmaceutical,
drug delivery/distribution systems, biopharmaceutical and medical
technology stocks. He was previously associated with EVEREN Securities,
Bristol-Myers Squibb and Buckingham Research. Mr. Kraws received a BS
from the State University of New York and an MBA from Cornell
University. Profile
pharmaceutical stocks over the past few weeks?
Mr. Kraws: I believe that the decline in pharmaceuticals has come as
some investors
